Loading market dashboard
Bio-Rad Laboratories, Inc.
BIOHealthcareNYSEUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Bio-Rad Laboratories, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $2.89B | $2.83B - $2.93B | -$516.88M | $13.76 | 1 |
| Dec 2029 | $2.81B | $2.75B - $2.85B | -$502.73M | $12.17 | 2 |
| Dec 2028 | $2.76B | $2.72B - $2.80B | -$494.08M | $11.147 | 3 |
| Dec 2027 | $2.66B | $2.60B - $2.73B | -$476.51M | $9.965 | 4 |
| Dec 2026 | $2.58B | $2.57B - $2.61B | -$461.38M | $9.042 | 4 |
| Dec 2025 | $2.58B | $2.53B - $2.62B | -$461.88M | $10.115 | 3 |
| Dec 2024 | $2.58B | $2.53B - $2.62B | -$461.77M | $10.283 | 4 |
| Dec 2023 | $2.56B | $2.51B - $2.60B | -$458.96M | -$46.188 | 3 |
| Dec 2022 | $2.82B | $2.79B - $2.84B | -$904.93M | $14.395 | 1 |
| Dec 2021 | $2.89B | $2.86B - $2.91B | -$46.02M | $15.309 | 1 |
| Dec 2020 | $2.44B | $2.42B - $2.47B | -$38.95M | $9.81 | 2 |
| Dec 2019 | $2.33B | $2.31B - $2.35B | $1.89B | $7.21 | 1 |